Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

UniProtKB - P17405 (ASM_HUMAN)

Entry version 213 (26 Feb 2020)
Sequence version 5 (12 Sep 2018)
Previous versions | rss
Help videoAdd a publicationFeedback
Protein

Sphingomyelin phosphodiesterase

Gene

SMPD1

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score:

Annotation score:5 out of 5

<p>The annotation score provides a heuristic measure of the annotation content of a UniProtKB entry or proteome. This score <strong>cannot</strong> be used as a measure of the accuracy of the annotation as we cannot define the 'correct annotation' for any given protein.<p><a href='/help/annotation_score' target='_top'>More...</a></p>-Experimental evidence at protein leveli <p>This indicates the type of evidence that supports the existence of the protein. Note that the 'protein existence' evidence does not give information on the accuracy or correctness of the sequence(s) displayed.<p><a href='/help/protein_existence' target='_top'>More...</a></p>

<p>This section provides any useful information about the protein, mostly biological knowledge.<p><a href='/help/function_section' target='_top'>More...</a></p>Functioni

Converts sphingomyelin to ceramide (PubMed:1840600, PubMed:18815062, PubMed:27659707, PubMed:25920558). Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol.Curated4 Publications
Isoform 2 lacks residues that bind the cofactor Zn2+ and has no enzyme activity.Curated1 Publication
Isoform 3 lacks residues that bind the cofactor Zn2+ and has no enzyme activity.Curated1 Publication

Miscellaneous

There are two types of sphingomyelinases: ASM (acid), and NSM (neutral).

Caution

Variants Gln-294 and Val-485 have been originally reported as disease-causing mutations in NPDA and NPDB (PubMed:12369017, PubMed:15221801). These variants have been reclassified as benign polymorphisms (PubMed:23430512).3 Publications

<p>This subsection of the <a href="http://www.uniprot.org/help/function%5Fsection">Function</a> section describes the catalytic activity of an enzyme, i.e. a chemical reaction that the enzyme catalyzes.<p><a href='/help/catalytic_activity' target='_top'>More...</a></p>Catalytic activityi

<p>This subsection of the 'Function' section provides information relevant to cofactors. A cofactor is any non-protein substance required for a protein to be catalytically active. Some cofactors are inorganic, such as the metal atoms zinc, iron, and copper in various oxidation states. Others, such as most vitamins, are organic.<p><a href='/help/cofactor' target='_top'>More...</a></p>Cofactori

Zn2+1 PublicationNote: Binds 2 Zn2+ ions per subunit (PubMed:27349982, PubMed:27725636). Zn2+ is particularly important for enzyme activity at neutral pH (PubMed:8702487).3 Publications

Sites

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the <a href="http://www.uniprot.org/help/function%5Fsection">Function</a> section indicates at which position the protein binds a given metal ion. The nature of the metal is indicated in the 'Description' field.<p><a href='/help/metal' target='_top'>More...</a></p>Metal bindingi208Zinc 1Combined sources1 Publication1
Metal bindingi210Zinc 1; via tele nitrogenCombined sources1 Publication1
Metal bindingi280Zinc 1Combined sources1 Publication1
Metal bindingi280Zinc 2Combined sources1 Publication1
Metal bindingi320Zinc 2Combined sources1 Publication1
Metal bindingi427Zinc 2; via tele nitrogenCombined sources1 Publication1
Metal bindingi459Zinc 2; via pros nitrogenCombined sources1 Publication1
Metal bindingi461Zinc 1; via tele nitrogenCombined sources1 Publication1

<p>The <a href="http://www.geneontology.org/">Gene Ontology (GO)</a> project provides a set of hierarchical controlled vocabulary split into 3 categories:<p><a href='/help/gene_ontology' target='_top'>More...</a></p>GO - Molecular functioni

Complete GO annotation on QuickGO ...

GO - Biological processi

Complete GO annotation on QuickGO ...

<p>UniProtKB Keywords constitute a <a href="http://www.uniprot.org/keywords">controlled vocabulary</a> with a hierarchical structure. Keywords summarise the content of a UniProtKB entry and facilitate the search for proteins of interest.<p><a href='/help/keywords' target='_top'>More...</a></p>Keywordsi

Molecular functionGlycosidase, Hydrolase
LigandMetal-binding, Zinc

Enzyme and pathway databases

Reactome - a knowledgebase of biological pathways and processes

More...Reactomei		R-HSA-1660662 Glycosphingolipid metabolism

SIGNOR Signaling Network Open Resource

More...SIGNORi		P17405

Chemistry databases

SwissLipids knowledge resource for lipid biology

More...SwissLipidsi		SLP:000001748

<p>This section provides information about the protein and gene name(s) and synonym(s) and about the organism that is the source of the protein sequence.<p><a href='/help/names_and_taxonomy_section' target='_top'>More...</a></p>Names & Taxonomyi

<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section provides an exhaustive list of all names of the protein, from commonly used to obsolete, to allow unambiguous identification of a protein.<p><a href='/help/protein_names' target='_top'>More...</a></p>Protein namesi
Recommended name:
Sphingomyelin phosphodiesterase (EC:3.1.4.126 Publications)
Alternative name(s):
Acid sphingomyelinase1 Publication
Short name:
aSMase
<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section indicates the name(s) of the gene(s) that code for the protein sequence(s) described in the entry. Four distinct tokens exist: 'Name', 'Synonyms', 'Ordered locus names' and 'ORF names'.<p><a href='/help/gene_name' target='_top'>More...</a></p>Gene namesi
Name:SMPD1
Synonyms:ASM
<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section provides information on the name(s) of the organism that is the source of the protein sequence.<p><a href='/help/organism-name' target='_top'>More...</a></p>OrganismiHomo sapiens (Human)
<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section shows the unique identifier assigned by the NCBI to the source organism of the protein. This is known as the 'taxonomic identifier' or 'taxid'.<p><a href='/help/taxonomic_identifier' target='_top'>More...</a></p>Taxonomic identifieri9606 [NCBI]
<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section contains the taxonomic hierarchical classification lineage of the source organism. It lists the nodes as they appear top-down in the taxonomic tree, with the more general grouping listed first.<p><a href='/help/taxonomic_lineage' target='_top'>More...</a></p>Taxonomic lineageiEukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo
<p>This subsection of the <a href="http://www.uniprot.org/help/names%5Fand%5Ftaxonomy%5Fsection">Names and taxonomy</a> section is present for entries that are part of a <a href="http://www.uniprot.org/proteomes">proteome</a>, i.e. of a set of proteins thought to be expressed by organisms whose genomes have been completely sequenced.<p><a href='/help/proteomes_manual' target='_top'>More...</a></p>Proteomesi
  • UP000005640 <p>A UniProt <a href="http://www.uniprot.org/manual/proteomes%5Fmanual">proteome</a> can consist of several components.<br></br>The component name refers to the genomic component encoding a set of proteins.<p><a href='/help/proteome_component' target='_top'>More...</a></p> Componenti: Chromosome 11

Organism-specific databases

Human Gene Nomenclature Database

More...HGNCi		HGNC:11120 SMPD1

Online Mendelian Inheritance in Man (OMIM)

More...MIMi		607608 gene

neXtProt; the human protein knowledge platform

More...neXtProti		NX_P17405

<p>This section provides information on the location and the topology of the mature protein in the cell.<p><a href='/help/subcellular_location_section' target='_top'>More...</a></p>Subcellular locationi

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionGraphics by Christian Stolte & Seán O’Donoghue; Source: COMPARTMENTS

Keywords - Cellular componenti

Lysosome, Secreted

<p>This section provides information on the disease(s) and phenotype(s) associated with a protein.<p><a href='/help/pathology_and_biotech_section' target='_top'>More...</a></p>Pathology & Biotechi

<p>This subsection of the 'Pathology and Biotech' section provides information on the disease(s) associated with genetic variations in a given protein. The information is extracted from the scientific literature and diseases that are also described in the <a href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim">OMIM</a> database are represented with a <a href="http://www.uniprot.org/diseases">controlled vocabulary</a> in the following way:<p><a href='/help/involvement_in_disease' target='_top'>More...</a></p>Involvement in diseasei

Niemann-Pick disease A (NPDA)18 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionAn early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.
Related information in OMIM
Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the 'Sequence' section describes natural variant(s) of the protein sequence.<p><a href='/help/variant' target='_top'>More...</a></p>Natural variantiVAR_060872105L → P in NPDA and NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains very low enzyme activity. 5 PublicationsCorresponds to variant dbSNP:rs751269562EnsemblClinVar.1
Natural variantiVAR_060877186P → L in NPDA; reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B. 1 PublicationCorresponds to variant dbSNP:rs1057517195EnsemblClinVar.1
Natural variantiVAR_068435211W → R in NPDA; results in less than 0.5% of wild-type activity. 1 Publication1
Natural variantiVAR_077311216L → R in NPDA. 1 Publication1
Natural variantiVAR_075324228C → R in NPDA. 1 Publication1
Natural variantiVAR_060882230R → C in NPDB and NPDA; some patients have a NPDA/NPDB intermediate phenotype. 5 PublicationsCorresponds to variants dbSNP:rs989639224 and dbSNP:rs1057516483EnsemblClinVarEnsembl.1
Natural variantiVAR_060883230R → H in NPDA; intermediate form with clinical features of both Niemann-Pick disease types A and B. 1 PublicationCorresponds to variant dbSNP:rs141387770EnsemblClinVar.1
Natural variantiVAR_060885243A → V in NPDA; intermediate form with clinical features of both Niemann-Pick disease types A and B. 1 PublicationCorresponds to variant dbSNP:rs1291958011Ensembl.1
Natural variantiVAR_075325247G → D in NPDA; severe decrease in activity; the mutant is highly unstable. 1 Publication1
Natural variantiVAR_060887247G → S in NPDA and NPDB. 4 PublicationsCorresponds to variant dbSNP:rs587779408EnsemblClinVar.1
Natural variantiVAR_060888248E → K in NPDA. 1 PublicationCorresponds to variant dbSNP:rs200763423EnsemblClinVar.1
Natural variantiVAR_015287250S → R in NPDA and NPDB; also found in patients with an intermediate form. 4 PublicationsCorresponds to variant dbSNP:rs750779804EnsemblClinVar.1
Natural variantiVAR_060889253D → E in NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B. 1 Publication1
Natural variantiVAR_068436253D → H in NPDA; results in loss of activity. 1 PublicationCorresponds to variant dbSNP:rs398123479EnsemblClinVar.1
Natural variantiVAR_077312255P → S in NPDA. 1 Publication1
Natural variantiVAR_060890280D → A in NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B. 1 Publication1
Natural variantiVAR_060893294Q → K in NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B. 3 PublicationsCorresponds to variant dbSNP:rs120074128EnsemblClinVar.1
Natural variantiVAR_005060304L → P in NPDA; in 23% of NPDA Ashkenazi Jewish patients; abolishes enzyme activity. 2 PublicationsCorresponds to variant dbSNP:rs120074124EnsemblClinVar.1
Natural variantiVAR_060895315Y → H in NPDA. 1 Publication1
Natural variantiVAR_077314319G → R in NPDA. 1 PublicationCorresponds to variant dbSNP:rs757934797EnsemblClinVar.1
Natural variantiVAR_015288321H → Y in NPDA. 2 Publications1
Natural variantiVAR_077316324T → P in NPDA; unknown pathological significance. 1 Publication1
Natural variantiVAR_060898343L → P in NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B. 2 Publications1
Natural variantiVAR_077317343L → R in NPDA. 1 Publication1
Natural variantiVAR_077318363L → R in NPDA; unknown pathological significance. 1 Publication1
Natural variantiVAR_060900369Y → C in NPDA. 2 PublicationsCorresponds to variant dbSNP:rs372287825EnsemblClinVar.1
Natural variantiVAR_005061384M → I in NPDA and NPDB. 2 PublicationsCorresponds to variant dbSNP:rs120074121EnsemblClinVar.1
Natural variantiVAR_075327387C → R in NPDA. 1 Publication1
Natural variantiVAR_077319391N → H in NPDA. 1 Publication1
Natural variantiVAR_005063391N → T in NPDA. 1 Publication1
Natural variantiVAR_060904392Missing in NPDA. 1 Publication1
Natural variantiVAR_077320393W → R in NPDA; intermediate form. 1 Publication1
Natural variantiVAR_060906423H → R in NPDA. 1 PublicationCorresponds to variant dbSNP:rs767492080Ensembl.1
Natural variantiVAR_077321426G → S in NPDA. 1 PublicationCorresponds to variant dbSNP:rs1554935136EnsemblClinVar.1
Natural variantiVAR_011388448Y → C in NPDA. 1 PublicationCorresponds to variant dbSNP:rs747143343EnsemblClinVar.1
Natural variantiVAR_060910452L → P in NPDA. 1 Publication1
Natural variantiVAR_015291465F → S in NPDA. 2 PublicationsCorresponds to variant dbSNP:rs1319643225Ensembl.1
Natural variantiVAR_060913469Y → S in NPDA. 1 PublicationCorresponds to variant dbSNP:rs267607074EnsemblClinVar.1
Natural variantiVAR_015292477P → L in NPDA and NPDB. 4 PublicationsCorresponds to variant dbSNP:rs753508874EnsemblClinVar.1
Natural variantiVAR_075329482Missing in NPDA; unknown pathological significance. 1 Publication1
Natural variantiVAR_060916484A → E in NPDA. 1 PublicationCorresponds to variant dbSNP:rs267607075EnsemblClinVar.1
Natural variantiVAR_077322494N → I in NPDA; intermediate form. 1 Publication1
Natural variantiVAR_060922498R → H in NPDA. 2 PublicationsCorresponds to variant dbSNP:rs120074117EnsemblClinVar.1
Natural variantiVAR_005066498R → L in NPDA; in 32% of NPDA Ashkenazi Jewish patients; nearly abolishes enzyme activity. 3 PublicationsCorresponds to variant dbSNP:rs120074117EnsemblClinVar.1
Natural variantiVAR_060926519Y → C in NPDA. 1 Publication1
Natural variantiVAR_060927535W → R in NPDB and NPDA; also in patients with an intermediate form. 3 PublicationsCorresponds to variant dbSNP:rs1554935555EnsemblClinVar.1
Natural variantiVAR_015293539Y → H in NPDA. 2 Publications1
Natural variantiVAR_075331572F → L in NPDA; results in decreased activity; decreased stability. 1 Publication1
Natural variantiVAR_005067579G → S in NPDA; impairs enzyme activity; also in patients with an intermediate form. 2 PublicationsCorresponds to variant dbSNP:rs120074119EnsemblClinVar.1
Natural variantiVAR_060931594Missing in NPDA. 1 Publication1
Natural variantiVAR_060932602R → H in NPDB and NPDA; expresses protein level comparable to wild-type SMPD1 expressing cells; retains about 10% residual enzyme activity. 3 PublicationsCorresponds to variant dbSNP:rs370129081EnsemblClinVar.1
Niemann-Pick disease B (NPDB)24 Publications
The disease is caused by mutations affecting the gene represented in this entry.
Disease descriptionA late-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Clinical signs involve only visceral organs. The most constant sign is hepatosplenomegaly which can be associated with pulmonary symptoms. Patients remain free of neurologic manifestations. However, a phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B. In Niemann-Pick disease type B, onset of the first symptoms occurs in early childhood and patients can survive into adulthood.
Related information in OMIM
Feature keyPosition(s)DescriptionActionsGraphical viewLength
Natural variantiVAR_06087051D → V in NPDB; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs748589919Ensembl.1
Natural variantiVAR_07532291C → H in NPDB; requires 2 nucleotide substitutions. 1 Publication1
Natural variantiVAR_06087194C → W in NPDB. 1 Publication1
Natural variantiVAR_060872105L → P in NPDA and NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains very low enzyme activity. 5 PublicationsCorresponds to variant dbSNP:rs751269562EnsemblClinVar.1
Natural variantiVAR_060873132V → A in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains 13% residual enzyme activity. 1 Publication1
Natural variantiVAR_060874139L → P in NPDB. 1 PublicationCorresponds to variant dbSNP:rs797044797EnsemblClinVar.1
Natural variantiVAR_011387159C → R in NPDB. 2 PublicationsCorresponds to variant dbSNP:rs727504166EnsemblClinVar.1
Natural variantiVAR_075323163L → P in NPDB. 1 PublicationCorresponds to variant dbSNP:rs780134410EnsemblClinVar.1
Natural variantiVAR_060875168G → R in NPDB; also in patients with an intermediate form. 2 Publications1
Natural variantiVAR_060876178I → N in NPDB. 1 PublicationCorresponds to variant dbSNP:rs749780769EnsemblClinVar.1
Natural variantiVAR_060878198A → P in NPDB. 1 PublicationCorresponds to variant dbSNP:rs797044798EnsemblClinVar.1
Natural variantiVAR_060879202R → C in NPDB. 1 PublicationCorresponds to variant dbSNP:rs749595299EnsemblClinVar.1
Natural variantiVAR_060880227L → M in NPDB. 1 Publication1
Natural variantiVAR_060881227L → P in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity. 2 PublicationsCorresponds to variant dbSNP:rs764317969EnsemblClinVar.1
Natural variantiVAR_060882230R → C in NPDB and NPDA; some patients have a NPDA/NPDB intermediate phenotype. 5 PublicationsCorresponds to variants dbSNP:rs989639224 and dbSNP:rs1057516483EnsemblClinVarEnsembl.1
Natural variantiVAR_060884234G → D in NPDB. 1 Publication1
Natural variantiVAR_005058244G → R in NPDB. 1 PublicationCorresponds to variant dbSNP:rs120074122EnsemblClinVar.1
Natural variantiVAR_060886246W → C in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity. 2 Publications1
Natural variantiVAR_060887247G → S in NPDA and NPDB. 4 PublicationsCorresponds to variant dbSNP:rs587779408EnsemblClinVar.1
Natural variantiVAR_005059248E → Q in NPDB; 30% residual activity. 1 PublicationCorresponds to variant dbSNP:rs200763423EnsemblClinVar.1
Natural variantiVAR_015287250S → R in NPDA and NPDB; also found in patients with an intermediate form. 4 PublicationsCorresponds to variant dbSNP:rs750779804EnsemblClinVar.1
Natural variantiVAR_075326258T → I in NPDB. 1 Publication1
Natural variantiVAR_077313282P → F in NPDB; requires 2 nucleotide substitutions. 1 Publication1
Natural variantiVAR_060891283A → T in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity. 2 PublicationsCorresponds to variant dbSNP:rs752148586Ensembl.1
Natural variantiVAR_060892291R → H in NPDB; also in patients with an intermediate form; unknown pathological significance. 2 PublicationsCorresponds to variant dbSNP:rs1803161EnsemblClinVar.1
Natural variantiVAR_068437314V → M in NPDB; results in 20% of wild-type activity. 1 PublicationCorresponds to variant dbSNP:rs1228068212EnsemblClinVar.1
Natural variantiVAR_077315320N → D in NPDB; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs779927660EnsemblClinVar.1
Natural variantiVAR_060896325P → A in NPDB; results in 1-4% of wild type activity. 3 PublicationsCorresponds to variant dbSNP:rs761308217EnsemblClinVar.1
Natural variantiVAR_060897332P → R in NPDB. 2 PublicationsCorresponds to variant dbSNP:rs202081954EnsemblClinVar.1
Natural variantiVAR_060899359A → D in NPDB; sphingomyelinase activity is decreased to 4% of wild-type activity; no effect on protein abundance; no effect on protein localization to lysosome; no effect on protein localization to extracellular space. 3 PublicationsCorresponds to variant dbSNP:rs797044800EnsemblClinVar.1
Natural variantiVAR_015289373P → S in NPDB. 2 Publications1
Natural variantiVAR_060901378R → H in NPDB; reduces enzyme activity; some patients have a NPDA/NPDB intermediate phenotype. 4 PublicationsCorresponds to variant dbSNP:rs559088058EnsemblClinVar.1
Natural variantiVAR_060902378R → L in NPDB. 1 Publication1
Natural variantiVAR_060903381S → P in NPDB. 1 Publication1
Natural variantiVAR_005061384M → I in NPDA and NPDB. 2 PublicationsCorresponds to variant dbSNP:rs120074121EnsemblClinVar.1
Natural variantiVAR_005062385N → S in NPDB. 1 PublicationCorresponds to variant dbSNP:rs120074123EnsemblClinVar.1
Natural variantiVAR_005064393W → G in NPDB; low sphingomyelin degradation rates. 1 PublicationCorresponds to variant dbSNP:rs120074125EnsemblClinVar.1
Natural variantiVAR_060905415A → V in NPDB. 1 PublicationCorresponds to variant dbSNP:rs1451199796Ensembl.1
Natural variantiVAR_015290423H → Y in NPDB; abolishes enzyme activity. 2 PublicationsCorresponds to variant dbSNP:rs120074126EnsemblClinVar.1
Natural variantiVAR_068438427H → R in NPDB; results in loss of activity; the patient also carries mutation H-228 that has sufficient activity to account for the Niemann-Pick disease type B phenotype. 1 PublicationCorresponds to variant dbSNP:rs794727629Ensembl.1
Natural variantiVAR_060907433C → R in NPDB. 1 PublicationCorresponds to variant dbSNP:rs779528546Ensembl.1
Natural variantiVAR_060908434L → P in NPDB. 1 Publication1
Natural variantiVAR_060909437W → C in NPDB. 1 Publication1
Natural variantiVAR_005065438S → R in NPDB. 1 PublicationCorresponds to variant dbSNP:rs267607073EnsemblClinVar.1
Natural variantiVAR_068439453A → D in NPDB. 1 Publication1
Natural variantiVAR_060911454A → V in NPDB. 1 PublicationCorresponds to variant dbSNP:rs1402734026EnsemblClinVar.1
Natural variantiVAR_060912458G → D in NPDB. 1 Publication1
Natural variantiVAR_075328476R → Q in NPDB; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs763566905EnsemblClinVar.1
Natural variantiVAR_060914476R → W in NPDB; some patients have a NPDA/NPDB intermediate phenotype. 4 PublicationsCorresponds to variant dbSNP:rs182812968EnsemblClinVar.1
Natural variantiVAR_015292477P → L in NPDA and NPDB. 4 PublicationsCorresponds to variant dbSNP:rs753508874EnsemblClinVar.1
Natural variantiVAR_060915482F → L in NPDB. 1 Publication1
Natural variantiVAR_060918488T → A in NPDB. 1 Publication1
Natural variantiVAR_060919490Y → N in NPDB. 1 PublicationCorresponds to variant dbSNP:rs398123477EnsemblClinVar.1
Natural variantiVAR_075330492G → S in NPDB. 1 PublicationCorresponds to variant dbSNP:rs144873307EnsemblClinVar.1
Natural variantiVAR_060920496G → S in NPDB. 1 PublicationCorresponds to variant dbSNP:rs1554935371EnsemblClinVar.1
Natural variantiVAR_060921498R → C in NPDB. 1 PublicationCorresponds to variant dbSNP:rs769904764EnsemblClinVar.1
Natural variantiVAR_060924516H → Q in NPDB. 1 Publication1
Natural variantiVAR_060925517E → V in NPDB. 1 PublicationCorresponds to variant dbSNP:rs142787001EnsemblClinVar.1
Natural variantiVAR_077324520I → L in NPDB. 1 Publication1
Natural variantiVAR_068440522N → S in NPDB. 1 Publication1
Natural variantiVAR_068441525Q → H in NPDB; results in 64% of wild-type activity. 1 Publication1
Natural variantiVAR_060927535W → R in NPDB and NPDA; also in patients with an intermediate form. 3 PublicationsCorresponds to variant dbSNP:rs1554935555EnsemblClinVar.1
Natural variantiVAR_077325549N → K in NPDB. 1 Publication1
Natural variantiVAR_060928551L → P in NPDB. 2 Publications1
Natural variantiVAR_060929565D → Y in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains 6.8% residual enzyme activity. 1 Publication1
Natural variantiVAR_075332577H → D in NPDB; unknown pathological significance. 1 Publication1
Natural variantiVAR_060930578K → N in NPDB. 1 PublicationCorresponds to variant dbSNP:rs747342458EnsemblClinVar.1
Natural variantiVAR_075333598Q → R in NPDB. 1 PublicationCorresponds to variant dbSNP:rs1554935731EnsemblClinVar.1
Natural variantiVAR_075334599L → F in NPDB; unknown pathological significance. 1 Publication1
Natural variantiVAR_060932602R → H in NPDB and NPDA; expresses protein level comparable to wild-type SMPD1 expressing cells; retains about 10% residual enzyme activity. 3 PublicationsCorresponds to variant dbSNP:rs370129081EnsemblClinVar.1
Natural variantiVAR_060933602R → P in NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains very low enzyme activity. 2 Publications1
Natural variantiVAR_075335610R → C in NPDB; unknown pathological significance. 1 PublicationCorresponds to variant dbSNP:rs375915127Ensembl.1
Natural variantiVAR_005068610Missing in NPDB; nearly abolishes enzyme activity; some patients have a NPDA/NPDB intermediate phenotype. 6 Publications1

Keywords - Diseasei

Disease mutation, Neurodegeneration, Niemann-Pick disease

Organism-specific databases

DisGeNET

More...DisGeNETi		6609

GeneReviews a resource of expert-authored, peer-reviewed disease descriptions.

More...GeneReviewsi		SMPD1

MalaCards human disease database

More...MalaCardsi		SMPD1
MIMi257200 phenotype
607616 phenotype

Open Targets

More...OpenTargetsi		ENSG00000166311

Orphanet; a database dedicated to information on rare diseases and orphan drugs

More...Orphaneti		77292 Niemann-Pick disease type A
77293 Niemann-Pick disease type B

The Pharmacogenetics and Pharmacogenomics Knowledge Base

More...PharmGKBi		PA35969

Miscellaneous databases

Pharos NIH Druggable Genome Knowledgebase

More...Pharosi		P17405 Tbio

Chemistry databases

ChEMBL database of bioactive drug-like small molecules

More...ChEMBLi		CHEMBL2760

Drug and drug target database

More...DrugBanki		DB00381 Amlodipine
DB09061 Cannabidiol
DB00477 Chlorpromazine
DB01151 Desipramine
DB14009 Medical Cannabis
DB14011 Nabiximols

Polymorphism and mutation databases

BioMuta curated single-nucleotide variation and disease association database

More...BioMutai		SMPD1

Domain mapping of disease mutations (DMDM)

More...DMDMi		224471897

<p>This section describes post-translational modifications (PTMs) and/or processing events.<p><a href='/help/ptm_processing_section' target='_top'>More...</a></p>PTM / Processingi

Molecule processing

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the 'PTM / Processing' section denotes the presence of an N-terminal signal peptide.<p><a href='/help/signal' target='_top'>More...</a></p>Signal peptidei1 – 46Add BLAST46
<p>This subsection of the 'PTM / Processing' section describes the extent of a polypeptide chain in the mature protein following processing.<p><a href='/help/chain' target='_top'>More...</a></p>ChainiPRO_000000232347 – 631Sphingomyelin phosphodiesteraseAdd BLAST585

Amino acid modifications

Feature keyPosition(s)DescriptionActionsGraphical viewLength
<p>This subsection of the <a href="http://www.uniprot.org/help/ptm%5Fprocessing%5Fsection">PTM / Processing</a> section specifies the position and type of each covalently attached glycan group (mono-, di-, or polysaccharide).<p><a href='/help/carbohyd' target='_top'>More...</a></p>Glycosylationi88N-linked (GlcNAc...) asparaginePROSITE-ProRule annotationCombined sources2 Publications1
<p>This subsection of the PTM / Processing":/help/ptm_processing_section section describes the positions of cysteine residues participating in disulfide bonds.<p><a href='/help/disulfid' target='_top'>More...</a></p>Disulfide bondi91 ↔ 167PROSITE-ProRule annotationCombined sources1 Publication
Disulfide bondi94 ↔ 159PROSITE-ProRule annotationCombined sources1 Publication
Disulfide bondi122 ↔ 133PROSITE-ProRule annotationCombined sources2 Publications
Glycosylationi177N-linked (GlcNAc...) asparaginePROSITE-ProRule annotationCombined sources2 Publications1
Disulfide bondi223 ↔ 228PROSITE-ProRule annotationCombined sources2 Publications
Disulfide bondi229 ↔ 252PROSITE-ProRule annotationCombined sources2 Publications
Glycosylationi337N-linked (GlcNAc...) asparaginePROSITE-ProRule annotationCombined sources2 Publications1
Disulfide bondi387 ↔ 433PROSITE-ProRule annotationCombined sources2 Publications
Glycosylationi397N-linked (GlcNAc...) asparaginePROSITE-ProRule annotationCombined sources2 Publications1
Glycosylationi505N-linked (GlcNAc...) asparagineCombined sources1 Publication1
Glycosylationi522N-linked (GlcNAc...) asparaginePROSITE-ProRule annotationCombined sources2 Publications1
Disulfide bondi586 ↔ 590PROSITE-ProRule annotationCombined sources2 Publications
Disulfide bondi596 ↔ 609PROSITE-ProRule annotationCombined sources2 Publications

Keywords - PTMi

Disulfide bond, Glycoprotein

Proteomic databases

jPOST - Japan Proteome Standard Repository/Database

More...jPOSTi		P17405

MassIVE - Mass Spectrometry Interactive Virtual Environment

More...MassIVEi		P17405

PaxDb, a database of protein abundance averages across all three domains of life

More...PaxDbi		P17405

PeptideAtlas

More...PeptideAtlasi		P17405

PRoteomics IDEntifications database

More...PRIDEi		P17405

ProteomicsDB: a multi-organism proteome resource

More...ProteomicsDBi		21562
53470 [P17405-1]
53471 [P17405-2]
53472 [P17405-3]

PTM databases

GlyConnect protein glycosylation platform

More...GlyConnecti		2081

iPTMnet integrated resource for PTMs in systems biology context

More...iPTMneti		P17405

Comprehensive resource for the study of protein post-translational modifications (PTMs) in human, mouse and rat.

More...PhosphoSitePlusi		P17405

<p>This section provides information on the expression of a gene at the mRNA or protein level in cells or in tissues of multicellular organisms.<p><a href='/help/expression_section' target='_top'>More...</a></p>Expressioni

Gene expression databases

Bgee dataBase for Gene Expression Evolution

More...Bgeei		ENSG00000166311 Expressed in right lobe of liver and 211 other tissues

ExpressionAtlas, Differential and Baseline Expression

More...ExpressionAtlasi		P17405 baseline and differential

Genevisible search portal to normalized and curated expression data from Genevestigator

More...Genevisiblei		P17405 HS

<p>This section provides information on the quaternary structure of a protein and on interaction(s) with other proteins or protein complexes.<p><a href='/help/interaction_section' target='_top'>More...</a></p>Interactioni

<p>This subsection of the <a href="http://www.uniprot.org/help/interaction%5Fsection">'Interaction'</a> section provides information about the protein quaternary structure and interaction(s) with other proteins or protein complexes (with the exception of physiological receptor-ligand interactions which are annotated in the <a href="http://www.uniprot.org/help/function%5Fsection">'Function'</a> section).<p><a href='/help/subunit_structure' target='_top'>More...</a></p>Subunit structurei

Monomer.

1 Publication

<p>This subsection of the '<a href="http://www.uniprot.org/help/interaction%5Fsection%27">Interaction</a> section provides information about binary protein-protein interactions. The data presented in this section are a quality-filtered subset of binary interactions automatically derived from the <a href="http://www.ebi.ac.uk/intact/">IntAct database</a>. It is updated on a monthly basis. Each binary interaction is displayed on a separate line.<p><a href='/help/binary_interactions' target='_top'>More...</a></p>Binary interactionsi

WithEntry#Exp.IntActNotes
P552106EBI-7095800,EBI-523958

Protein-protein interaction databases

The Biological General Repository for Interaction Datasets (BioGrid)

More...BioGridi		112493, 14 interactors

Protein interaction database and analysis system

More...IntActi		P17405, 11 interactors

Molecular INTeraction database

More...MINTi		P17405

STRING: functional protein association networks

More...STRINGi		9606.ENSP00000340409

Miscellaneous databases

RNAct, Protein-RNA interaction predictions for model organisms.

More...RNActi		P17405 protein

<p>This section provides information on the tertiary and secondary structure of a protein.<p><a href='/help/structure_section' target='_top'>More...</a></p>Structurei

Secondary structure

1631
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details